NCT02055287View on ClinicalTrials.gov

Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

LY03004

Trial Locations (2)

78754

Community Clinical Research Inc, Austin

92868

Neuropsychiatric Research Center of Orange County, Orange

All Listed Sponsors
lead

Luye Pharma Group Ltd.

INDUSTRY

NCT02055287 - Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective Disorder | Biotech Hunter | Biotech Hunter